These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9222342)

  • 41. A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK.
    Martin F; Fedina A; Youshya S; Taylor GP
    J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1336-40. PubMed ID: 20660921
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).
    Olindo S; Jeannin S; Saint-Vil M; Signate A; Edimonana-Kaptue M; Joux J; Merle H; Richard P; Granjeaud S; Cabre P; Smadja D; Cesaire R; Lezin A
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006304. PubMed ID: 29554087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid onset and progression of myelopathy following an STI: a case for screening?
    Caswell RJ; Nall P; Boothby M; Taylor GP
    Sex Transm Infect; 2019 Jun; 95(4):244-245. PubMed ID: 30824578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
    Talledo M; López G; Huyghe JR; Verdonck K; Adaui V; González E; Best I; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2010 Mar; 82(3):460-6. PubMed ID: 20087941
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Active production of anti-human T-lymphotropic virus type I (HTLV-I) IgM antibody in HTLV-I-associated myelopathy.
    Nagasato K; Nakamura T; Ohishi K; Shibayama K; Motomura M; Ichinose K; Tsujihata M; Nagataki S
    J Neuroimmunol; 1991 May; 32(2):105-9. PubMed ID: 2013615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Indigenous tropical spastic paraparesis in Madrid (Spain). Experience on screening of human T-lymphotropic virus.
    Ponce-Alonso M; Del Corral-Corral I; Ortiz-Rivera M; Anciones-Martín C; Mateos-Lindemann ML
    Enferm Infecc Microbiol Clin; 2017; 35(7):441-443. PubMed ID: 26282070
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I).
    Gessain A; Gout O
    Ann Intern Med; 1992 Dec; 117(11):933-46. PubMed ID: 1443956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Probable HTLV-I/II Tropical Spastic Paraparesis Patient from Ethiopia: A Case Report.
    Melka D; Zebenigus M
    Ethiop J Health Sci; 2022 Jul; 32(4):865-868. PubMed ID: 35950079
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibody titers to HTLV-I-p40tax protein and gag-env hybrid protein in HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with increased HTLV-I proviral DNA load.
    Kira J; Nakamura M; Sawada T; Koyanagi Y; Ohori N; Itoyama Y; Yamamoto N; Sakaki Y; Goto I
    J Neurol Sci; 1992 Jan; 107(1):98-104. PubMed ID: 1578240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human T-lymphotropic virus type I-associated myelopathy. A case report.
    Joubert J; van As AD; Lecatsas G; Bos P
    S Afr Med J; 1991 Dec; 80(11-12):592-3. PubMed ID: 1745951
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of cerebrospinal fluid CXCL10 and neopterin as biomarkers in HTLV-1-associated myelopathy/tropical spastic paraparesis treated with steroids.
    Yamauchi J; Sato T; Yagishita N; Araya N; Hasegawa D; Tsutsumi S; Nagasaka M; Coler-Reilly A; Inoue E; Takata A; Hasegawa Y; Yamano Y
    J Neurol Neurosurg Psychiatry; 2020 Mar; 91(3):321-323. PubMed ID: 31662348
    [No Abstract]   [Full Text] [Related]  

  • 52. HTLV-1 proviral load in peripheral blood mononuclear cells quantified in 100 HAM/TSP patients: a marker of disease progression.
    Olindo S; Lézin A; Cabre P; Merle H; Saint-Vil M; Edimonana Kaptue M; Signate A; Césaire R; Smadja D
    J Neurol Sci; 2005 Oct; 237(1-2):53-9. PubMed ID: 15972218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human T cell lymphotropic virus type 1 in Zimbabwe.
    Houston S; Thornton C; Emmanuel J; Latif A
    Trans R Soc Trop Med Hyg; 1994; 88(2):170-2. PubMed ID: 8036662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Human T lymphotropic virus type 1 (HTLV-1) proviral load in asymptomatic carriers, HTLV-1-associated myelopathy/tropical spastic paraparesis, and other neurological abnormalities associated with HTLV-1 infection.
    Silva MT; Harab RC; Leite AC; Schor D; Araújo A; Andrada-Serpa MJ
    Clin Infect Dis; 2007 Mar; 44(5):689-92. PubMed ID: 17278060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.
    Romanelli LC; Caramelli P; Martins ML; Gonçalves DU; Proietti FA; Ribas JG; Araújo MG; Carneiro-Proietti AB
    AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1199-202. PubMed ID: 23617363
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Burbelo PD; Meoli E; Leahy HP; Graham J; Yao K; Oh U; Janik JE; Mahieux R; Kashanchi F; Iadarola MJ; Jacobson S
    Retrovirology; 2008 Oct; 5():96. PubMed ID: 18937847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two Babinski signs in seropositive (HAM) and seronegative tropical spastic paraparesis.
    Leon-Sarmiento FE; Calderon A; Hernandez HG
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):695-7. PubMed ID: 18949264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
    Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
    J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Tropical spastic paraparesis in a non tropical region].
    Pias-Peleteiro L; Pias-Peleteiro JM; Arias M
    Rev Neurol; 2015 Oct; 61(8):357-62. PubMed ID: 26461129
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis.
    Gotuzzo E; Cabrera J; Deza L; Verdonck K; Vandamme AM; Cairampoma R; Vizcarra D; Cabada M; Narvarte G; De las Casas C
    Clin Infect Dis; 2004 Oct; 39(7):939-44. PubMed ID: 15472843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.